The Implementation of a Health Care Worker Screening Program Based on the Advanta RT-qPCR Saliva Assay in a Tertiary Care Referral Hospital in Northern Greece.

COVID-19 RT-qPCR SARS-CoV-2 health care workers saliva screening

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
02 Dec 2022
Historique:
received: 27 10 2022
revised: 24 11 2022
accepted: 29 11 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 24 12 2022
Statut: epublish

Résumé

Health care workers are at increased risk of acquiring SARS-CoV-2 infection due to different exposures in the community and in hospital settings. Interventions implemented to avoid nosocomial outbreaks include preventive testing strategies. In this report, we present results from the mass screening program applied in our hospital to all professionals, irrespective of symptoms or risk of exposure. We processed saliva specimens with real-time reverse transcription polymerase chain reaction. The total number of samples received was 43,726. Positive results were 672 and average positivity rate was 1.21%. The average positivity rate was similar to the positivity rate in the community in Greece and EU. More specifically, 80.5% of the positive participants care for patients in their daily activities, 31% experienced no symptoms before receiving the positive result, 46.1% reported a close contact with a patient or infected coworkers and 32.8% reported a close contact with infected family members. We believe that the identification of asymptomatic carriers has proved the effectiveness of the screening program by preventing the putative nosocomial spread of the virus and the depletion of workforce. In conclusion, in times of high incidence in the community, the periodic testing of health care personnel is wise and relevant for implementation costs.

Identifiants

pubmed: 36556375
pii: life12122011
doi: 10.3390/life12122011
pmc: PMC9787401
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Lancet. 2020 Oct 31;396(10260):1393
pubmed: 33129386
Antimicrob Resist Infect Control. 2021 Jan 6;10(1):7
pubmed: 33407833
N Engl J Med. 2020 Sep 24;383(13):1283-1286
pubmed: 32857487
Science. 2020 May 8;368(6491):
pubmed: 32234805
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):477-481
pubmed: 32298247
N Engl J Med. 2020 May 21;382(21):2005-2011
pubmed: 32220208
J Infect. 2020 Sep;81(3):411-419
pubmed: 32504743
Euro Surveill. 2020 Apr;25(14):
pubmed: 32290904
Front Med (Lausanne). 2021 Mar 12;8:636160
pubmed: 33777979
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1337-1344
pubmed: 32298146
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Lancet. 2020 May 2;395(10234):e77-e78
pubmed: 32333843
J Assoc Med Microbiol Infect Dis Can. 2020 Dec 31;5(4):245-250
pubmed: 36340051
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200268
pubmed: 34053255
PLoS One. 2021 Nov 5;16(11):e0258700
pubmed: 34739484
Diagnostics (Basel). 2021 Sep 26;11(10):
pubmed: 34679464
Lancet. 2020 May 2;395(10234):1418-1420
pubmed: 32305073
JAMA Netw Open. 2021 Jan 4;4(1):e2035057
pubmed: 33410879
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
BMC Infect Dis. 2022 Jul 2;22(1):587
pubmed: 35780088
Front Public Health. 2021 Jul 26;9:644702
pubmed: 34381749
Am J Epidemiol. 2021 Jan 4;190(1):161-175
pubmed: 32870978
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
Lancet Respir Med. 2021 Jun;9(6):562-564
pubmed: 33887248
Elife. 2020 May 11;9:
pubmed: 32392129
Clin Microbiol Infect. 2020 Oct;26(10):1413.e9-1413.e13
pubmed: 32569835
Antimicrob Resist Infect Control. 2020 Dec 7;9(1):192
pubmed: 33287908
Clin Microbiol Infect. 2022 May;28(5):672-680
pubmed: 35124258
Lancet. 2020 May 23;395(10237):1608-1610
pubmed: 32401714
Lancet Infect Dis. 2020 Dec;20(12):1381-1389
pubmed: 32822577
JAMA Netw Open. 2020 May 1;3(5):e209673
pubmed: 32437576
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
J Hosp Infect. 2021 Apr;110:178-183
pubmed: 33571558
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
JAMA. 2020 May 19;323(19):1915-1923
pubmed: 32275295
PLoS One. 2021 Apr 22;16(4):e0250021
pubmed: 33886627
J Clin Microbiol. 2021 Apr 20;59(5):
pubmed: 33504593
Medicine (Baltimore). 2021 Dec 23;100(51):e28398
pubmed: 34941176

Auteurs

Sofia Balaska (S)

Department of Microbiology, AHEPA University Hospital, Medical School Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.

Eleftheria Parasidou (E)

Department of Microbiology, AHEPA University Hospital, Medical School Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.

Anna Takardaki (A)

Department of Microbiology, AHEPA University Hospital, Medical School Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.

Paraskevoula Koutra (P)

Department of Microbiology, AHEPA University Hospital, Medical School Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.

Dimitra Chrysafi (D)

Department of Microbiology, AHEPA University Hospital, Medical School Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.

Areti Tychala (A)

Department of Microbiology, AHEPA University Hospital, Medical School Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.

Simeon Metallidis (S)

First Department of Internal Medicine, Infectious Diseases Division, AHEPA University Hospital, Medical School Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.

Georgios Meletis (G)

Department of Microbiology, AHEPA University Hospital, Medical School Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.

Lemonia Skoura (L)

Department of Microbiology, AHEPA University Hospital, Medical School Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.

Classifications MeSH